Hepatology & TransplantCourse recording2026
Houston Methodist Transplanting Hope 2026 — liver transplantation and alcohol use disorder, from selection to relapse prevention
Recorded on 20 March 2026, Houston Methodist Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder 2026 confronts the questions transplant committees argue over: who with alcohol-related liver disease should be listed, whether the six-month abstinence rule still makes sense, and how to stop relapse once the new liver is in. Hepatology, addiction medicine and transplant faculty share the stage, and the programme also reaches heart failure, kidney transplant and team leadership.
- 21listed sessions
- 7 h 37 mlisted running time
- 3panel discussions
- 2026edition
What you’ll be able to do
- Explain how alcohol drives steatotic liver disease and contributes to liver cancer
- Describe the link between the gut microbiome and addiction
- Apply psychosocial, medical and ethical criteria when selecting AUD patients for liver transplant
- Evaluate early transplant for alcohol-associated hepatitis and absolute contraindications in ALD
- Identify relapse risk and organise inpatient, outpatient and pharmacological AUD treatment
- Weigh the emerging case for GLP-1 receptor agonists in alcohol addiction
Inside the course
Science of alcohol injury and addiction
Alcohol’s effect on MASLD and liver cancer, the microbiome-addiction axis and GLP-1 agonists as a possible treatment.
Liver transplantation and alcohol use disorder: selection
Alcohol-associated hepatitis as a transplant indication, absolute contraindications, the debate over six months’ abstinence and the Houston Methodist experience with ALD transplants.
Keeping patients well after transplant
Relapse reduction, inpatient and community-based AUD treatment and medical therapy in ALD.
Running the programme
Emotional intelligence in transplant leadership, a medical review board exercise, AUD in heart failure and kidney transplantation, and panels on intubated candidates and ethically difficult cases.
Built for
- Hepatologists and transplant surgeonsEvidence and debate behind listing decisions in ALD.
- Addiction specialists and psychiatristsWhere their assessments fit in the transplant pathway.
- Social workers, psychologists and transplant nursesPractical relapse-prevention and support strategies.
- Nephrology and cardiology teamsDedicated talks on AUD in kidney transplant and heart failure.
Faculty & syllabus
Sessions and running times 21 sessions
- Transplanting Hope: The Intersection of Liver Transplantation and Alcohol Use Disorder (31:29)
- Emotional Intelligence and Managing a Transplant Program (14:19)
- Managing Individuals with AUD and Addiction (31:20)
- Alcohol-Associated Hepatitis and Liver Transplantation (17:39)
- 3 Questions: Managing a Transplant Medical Review Board (18:15)
- Effects of Alcohol on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (15:10)
- Intestinal Microbiome and Addiction (16:21)
- Panel Discussion: Management of Patients with Alcoholic Liver Disease (23:27)
- Strategies to Reduce Alcohol Relapse After Liver Transplantation (22:08)
- Inpatient Management of Alcohol Use Disorder Post Transplant (12:39)
- Role of Alcohol and/in Liver Cancer (18:01)
- Absolute Contraindications for Liver Transplant in ALD (17:48)
- Why Is There Reluctance to Drop the 6-Month Abstinence Rule for AUD Liver Transplant? (20:51)
- Medical Management of AUD in ALD (23:05)
- GLP-1 Receptor Agonists and Addiction (16:25)
- Liver Transplantation for Alcohol-Association Liver Disease at Houston Methodist Hospital (08:16)
- Panel Discussion: Challenges of Evaluating and Treating Intubated Patients for Liver Transplants (18:39)
- Outpatient Community Based Treatment of Individuals with Alcohol Use Disorder and Addiction (16:09)
- Alcohol Use Disorder and Advanced Heart Failure (11:26)
- AUD and Kidney Transplantation (52:03)
- Panel Discussion: Case Studies on Ethical and Clinical Challenges of Liver Transplantation for Patients with Alcohol Use Disorder (52:03)
Before you buy
Is it 11 videos or 21?
The package is described as 11 videos, yet 21 timed sessions are listed, so several talks are probably combined within single files.
Are the last two sessions really the same length?
The kidney transplant talk and the closing ethics panel are both listed at 52:03, which may indicate a shared recording; the listed total of 7 h 37 m counts both.
Are slides or speaker names included?
No PDFs are supplied, and the session list does not name the speakers.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Videos, no PDFs |
|---|---|
| Date | 20 March 2026 |
| Contents | 21 sessions listed (packaged as 11 videos) |
| Publisher | Houston Methodist |
| Department | Gastroenterology |
| Delivery | Instant download · lifetime re-download |
Related products
Endocrine /Nutrition
AdventHealth Updates in Gastroenterology and Hepatology 2025
Anesthesiology
